bluebird bio Inc - Strategy, SWOT and Corporate Finance Report

bluebird bio Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Bluebird Bio Inc (bluebird bio) is a clinical stage biotechnology company that focuses on the development of new gene therapies for the treatment of severe genetic diseases and cancer. The company develops its products based on integrated product platforms such as gene therapy, cancer immunotherapy and gene editing. Its product pipeline includes Lenti D for the treatment of cerebral adrenoleukodystrophy (CALD); LentiGlobin for the treatment of transfusion-dependent beta thalassemia and sickle cell disease, besides compounds under development for the treatment of various cancers. The company has collaboration with pharmaceutical companies to discover, develop and commercialize gene therapy products. bluebird bio is headquartered in Cambridge, Massachusetts, the US.

Scope

  • Detailed information on bluebird bio Inc required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting bluebird bio Inc in the form of a SWOT analysis
  • An in-depth view of the business model of bluebird bio Inc including a breakdown and examination of key business segments
  • News about bluebird bio Inc, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of bluebird bio Inc and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess bluebird bio Inc as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on bluebird bio Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Global Blood Therapeutics Inc

Acceleron Pharma Inc

Bellicum Pharmaceuticals Inc

Adaptimmune LLC

Intellia Therapeutics Inc

GlycoMimetics Inc

Juno Therapeutics Inc

Sangamo Therapeutics Inc

ApoPharma Inc

Global Blood Therapeutics Inc

Acceleron Pharma Inc

Bellicum Pharmaceuticals Inc

Adaptimmune LLC

Intellia Therapeutics Inc

GlycoMimetics Inc

Juno Therapeutics Inc

Sangamo Therapeutics Inc

ApoPharma Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

bluebird bio Inc - Key Facts

bluebird ...

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

bluebird bio Inc - Key Facts

bluebird bio Inc - Key Employees

bluebird bio Inc - Key Employee Biographies

bluebird bio Inc - Major Products and Services

bluebird bio Inc - History

bluebird bio Inc - Company Statement

bluebird bio Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

bluebird bio Inc - Business Description

bluebird bio Inc - Corporate Strategy

bluebird bio Inc - SWOT Analysis

SWOT Analysis - Overview

bluebird bio Inc - Strengths

bluebird bio Inc - Weaknesses

bluebird bio Inc - Opportunities

bluebird bio Inc - Threats

bluebird bio Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

bluebird bio Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 01, 2019: bluebird bio appoints Joanne Smith-Farrell, Ph.D., to Chief Business Officer

Apr 16, 2019: bluebird bio: Entry into a Material Definitive Agreement

Mar 25, 2019: bluebird bio Statement on European Regulatory Status of LentiGlobin

Mar 22, 2019: Bluebird bio Opens State-of-the-Art Gene and Cell Therapy Manufacturing Facility in Durham, North Carolina

Mar 22, 2019: bluebird bio Opens State-of-the-Art Gene and Cell Therapy Manufacturing Facility in Durham, North Carolina

Feb 21, 2019: bluebird bio reports fourth quarter and full year 2018 financial results and highlights operational progress

Feb 21, 2019: bluebird bio reports fourth quarter and full year 2018 financial results and highlights operational progress

Feb 11, 2019: bluebird bio names Chip Baird as Chief Financial Officer

Nov 21, 2018: Cryoport Opens Logistics Center in Livingston, NJ, US

Nov 01, 2018: bluebird bio reports third quarter 2018 financial results and highlights operational progress

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

bluebird bio Inc, Key Facts

bluebird bio Inc, Key Employees

bluebird bio Inc, Key Employee Biographies

bluebird bio Inc, Major Products and ...

List of Tables

bluebird bio Inc, Key Facts

bluebird bio Inc, Key Employees

bluebird bio Inc, Key Employee Biographies

bluebird bio Inc, Major Products and Services

bluebird bio Inc, History

bluebird bio Inc, Other Locations

bluebird bio Inc, Subsidiaries

bluebird bio Inc, Key Competitors

bluebird bio Inc, Ratios based on current share price

bluebird bio Inc, Annual Ratios

bluebird bio Inc, Annual Ratios (Cont...1)

bluebird bio Inc, Interim Ratios

bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

bluebird bio Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

bluebird bio Inc, Performance Chart (2014 - 2018)

bluebird bio Inc, Ratio Charts

bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, ...

List of Figures

bluebird bio Inc, Performance Chart (2014 - 2018)

bluebird bio Inc, Ratio Charts

bluebird bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

bluebird bio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports